GSTM1 and colorectal carcinoma: found considerably lower sensitivity at various thresholds for CRC and advanced adenoma (not the same as HRA; please refer to the paper for a precise definition) combined.12 In subjects with f-Hb of 80–119 μg/g, which would not trigger further investigation in the current programme in England, just under 4% had CRC (Table 5).